Details of Disease

Disease Name

Blood transfusion

Disease Class

QB98: Undiagnosed blood transfusion

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISH3QF7: Blood transfusion

ICD-11

ICD-11: QB98

ICD-10

ICD-10: Z51.3

Expand ICD-11

'QB98

Expand ICD-10

'Z51.3

General Information of Disease (ID: DISH3QF7)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Hextend	DMAL8MT	Approved	NA	[1]
Polygeline	DMHQFKC	Approved	NA	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Human hemoglobin	DMTLD34	Phase 3	NA	[2]
CLT-008	DM14CEO	Phase 2	NA	[3]
INTERCEPT	DM3PBMR	Phase 2	NA	[4]
PentaLyte	DMN2TQO	Phase 2	Small molecular drug	[5]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
HRC-101	DMEZ5P2	Terminated	NA	[6]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
M-101	DMWRA95	Investigative	Small molecular drug	[7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT00421200) Phase III Study of Hemospan to Prevent Hypotension in Hip Arthroplasty. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT02282215) Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia. U.S. National Institutes of Health.
4	Clinical pipeline report, company report or official report of Cerus.
5	BioTime Announces New Patent in China. BioTime, Inc. July 12, 2005.
6	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016356)
7	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.